Levodopa-Induced Dyskinesia in Parkinson's Disease
This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from ‘bench to bedside’. Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to understanding ri...
Tallennettuna:
| Yhteisötekijä: | |
|---|---|
| Muut tekijät: | , |
| Aineistotyyppi: | Elektroninen E-kirja |
| Kieli: | English |
| Julkaistu: |
London :
Springer London : Imprint: Springer,
2014.
|
| Painos: | 1st ed. 2014. |
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/978-1-4471-6503-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Sisällysluettelo:
- Phenomenology of Levodopa-Induced Dyskinesia
- Dyskinesia Rating Scales in Parkinson's Disease
- Epidemiology of Levodopa-Induced Dyskinesia
- Risk Factors for Levodopa-Induced Dyskinesia
- Pharmacological Treatment Options for Levodopa-Induced Dyskinesia
- Surgical Options for Levodopa-Induced Dyskinesia in Parkinson’s Disease
- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
- Pharmacological Properties of Levodopa
- Dopamine Receptors and LID
- The Serotonergic System In Levodopa-Induced Dyskinesia
- The Opioid System in Levodopa-Induced Dyskinesia
- Glutamate Receptors and Levodopa-Induced Dyskinesia
- Cannabinoids and Levodopa-Induced Dyskinesia
- The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia
- Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia
- New Clinical Trials for Levodopa-Induced Dyskinesia
- Preclinical Models of Levodopa-Induced Dyskinesia
- Final Thoughts: Summary and Future Therapeutic Strategies in LID.